Stock Events

Stock Events

Recce Pharmaceuticals (RCE.AU) Q3 2024 Earnings

30AugConfirmed

Q4 2022

Q2 2023

Q1 2024

Q3 2024

-0.06

-0.05

-0.05

-0.04

Details

Expected EPS

N/A

Actual EPS

-0.05711972744970798

Surprise EPS

-0.06

Surprise Percent

+∞%

Description

Recce Pharmaceuticals (RCE.AU) has reported earnings of -0.05711972744970798 per share for Q3 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.